510(k) device
Vidas B.r.a.h.m.s. Pct (Pct)
bioMerieux, Inc. · Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT, Class II) · First FDA decision Jun 28, 2016, newest Jun 28, 2016Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Vidas B.r.a.h.m.s Pct"
MAUDE reports
0
Brand "Vidas B.r.a.h.m.s Pct", since 2015
PubMed studies
7
Mentioning "Vidas B.r.a.h.m.s Pct"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vidas B.r.a.h.m.s. Pct (Pct)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K160911 · Decided Jun 28, 2016 · 88 days after receipt
Device type: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Vidas B.r.a.h.m.s Pct", any status and sponsor, newest update first.
- Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin LevelPivotal-lookingTerminated
National Institute of Allergy and Infectious Diseases (NIAID)NIH
NCT03341273 · 514 participants · Start Dec 8, 2017 · Primary completion Mar 30, 2020
Device: VIDAS B.R.A.H.M.S Procalcitonin Test (PCT) · For: Lower Respiratory Tract Infection
Sites: Atlanta, Georgia; Decatur, Georgia; Durham, North Carolina · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vidas B.r.a.h.m.s Pct", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMT
13 reports: 13 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Vidas B.r.a.h.m.s Pct"[tiab]. The summary above synthesizes these.
- Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
Wang G, Wan Y, Lin G, et al. · J Immunol Methods · 2020Comparative Study, Research Support, Non-U.S. Gov't
- Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.
Garrigan C, Han J, Tolomeo P, et al. · Am J Transl Res · 2016
- Role of procalcitonin in diagnosis of community acquired pneumonia in Children.
Ratageri VH, Panigatti P, Mukherjee A, et al. · BMC Pediatr · 2022
- Diagnostic value of sTREM-1 and procalcitonin levels in the early diagnosis of sepsis.
Aksaray S, Alagoz P, Inan A, et al. · North Clin Istanb · 2016
- Diagnostic usefulness of sCD163, procalcitonin and neopterin for sepsis risk assessment in critically ill patients.
Sapa A, Rak A, Wybieralska M, et al. · Adv Clin Exp Med · 2017
- Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays.
Hausfater P, Brochet C, Freund Y, et al. · Clin Chem Lab Med · 2010Comparative Study
- Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever.
Kim MH, Lim G, Kang SY, et al. · Yonsei Med J · 2011
Other devices of this type
Also filed under product code PMT.
- VITROS BRAHMS PCT Reagent Pack and CalibratorsOrtho Clinical Diagnostics · 510(k) 2020
- Atellica IM BRAHMS Procalcitonin (PCT)Siemens Healthcare Diagnostics, Inc. · 510(k) 2018
- Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5Roche Diagnostics · 510(k) 2016
- B.R.A.H.M.S PCT sensitive KRYPTORBrahms GmbH · De Novo 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.